Stay updated on IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.

Latest updates to the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check13 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology across its content. The underlying study page still displays a 403 error.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded downloadable Study Protocol and Statistical Analysis Plan, and expanded the record with a 57-site Locations section and related metadata, enhancing the page's documentation and geographic scope.SummaryDifference92%

- Check41 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header, replacing the previous study content and documents with an error screen and a Home button. This indicates the study record is currently inaccessible to users.SummaryDifference20%

Stay in the know with updates to IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.